Sort
1,049,261 grants matching “t cell”
PROGRAMMING SEED CELLS TO GROW AND DIFFERENTIATE INTO DEFINED PATTERNS
$2,409,578Massachusetts Institute Of Technology · · FY2017 · Department of the Army
The CSBC Research Center for Cancer Systems Immunology at MSKCC
$2,409,446Christina S Leslie · Sloan-Kettering Inst Can Research · U54 · FY2018 · CA
Multidisciplinary Approaches to HDL Structure, Assembly and Function
$2,409,435Jere P Segrest · Vanderbilt University Medical Center · P01 · FY2020 · HL
Scientific innovation for personalized severe asthma management
$2,409,373Benjamin M Gaston · Indiana University Indianapolis · P01 · FY2022 · HL
Pathophysiologic Consequences of Survival Signaling in Neuroblastoma
$2,409,315Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Biomarker Rich Clinical Trial of an Innovative Antibody Antagonist of TNFR2 in Non-Hodgkin Lymphoma Featuring Cutaneous T Cell Lymphoma (CTCL).
$2,409,283David G Brooks · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2025 · CA
GENETIC ANALYSIS OF MOUSE CHROMOSOME 11
$2,409,277Baylor College Of Medicine · P01 · FY2001 · CA
Experimental-data-based in-silico data generation platform to improve the accuracy and reliability of single-cell and spatial omics data analysis
$2,409,233Jingyi Jessica Li · Fred Hutchinson Cancer Center · R01 · FY2025 · HG
Life Course Cancer Epidemiology Cohort in Women
$2,409,183Walter C. Willett · Harvard School Of Public Health · U01 · FY2021 · CA
Genetic Basis Of Cortical Malfunction In Schizophrenia
$2,409,110Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2012 · MH
Development of Novel Therapeutic Strategies in Human Leukemias
$2,408,966James D Griffin · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Retinal aging and inherited neurodegenerative diseases
$2,408,833Anand Swaroop · National Eye Institute · ZIA · FY2013 · EY
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,408,617Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2023 · AG
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$2,408,401Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Immunopathogenesis of Fungal Infections
$2,408,398Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Physics of collective cellular migration in lung health and disease
$2,408,374Jeffrey J Fredberg · Harvard School Of Public Health · P01 · FY2017 · HL
Harnessing the power of experimental genetic crosses and systems genetics to probe drug resistance in malaria
$2,408,349Michael T Ferdig · University Of Notre Dame · P01 · FY2017 · AI
Scientific innovation for personalized severe asthma management
$2,408,164Benjamin M Gaston · Indiana University Indianapolis · P01 · FY2025 · HL
Immunological responses to pan-CoV vaccines
$2,408,043Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2021 · AI
STEM CELLS AND CARDIOVASCULAR REPAIR
$2,407,992Charles E Murry · University Of Washington · P01 · FY2013 · HL
Multi-component HIV Vaccines Using Engineered Envelopes
$2,407,540Novartis Vaccines And Diagnostics, Inc. · P01 · FY2004 · AI
High-Throughput Nanoscale Approaches to Studying and Inhibiting Amyloid Toxicity
$2,407,500Timothy Lu · Massachusetts Institute Of Technology · DP2 · FY2011 · OD
Accelerating drug development and repurposing using systematic genetic interactio
$2,407,500Michael C Bassik · Stanford University · DP2 · FY2014 · HD
Genetic Analysis of Resistance to Viral Infection
$2,407,377Bruce A Beutler · Scripps Research Institute, The · P01 · FY2007 · AI
NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network
$2,407,344Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2018 · CA